Pharmaceutical group UCB invests 100 million in Switzerland
Belgian pharmaceutical group UCB announces a CHF 100 million investment in Bulle, Switzerland.
Published 2h1 sourceNotable
Lire en français
≈ 19s
The fact
The Fribourg site is one of its two main factories and marks 30 years in the country.
The company is also expanding its presence in North America.
Click the link to read an article on the topic: